Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: David Israel-Rosen who wrote (769)	5/7/1998 1:56:00 PM
From: one putt	Respond to of 1491

In Lady's defense, the Dow Jones article was much clearer than the PR Newswire article. Perhaps that is what she was refering to...... Craig

To: David Israel-Rosen who wrote (769)	5/7/1998 2:04:00 PM
From: Zvi Steinberg	Read Replies (2) \| Respond to of 1491

David, Please spare us from your disgraceful emotional outbursts, juvenile temper tantrums, pomposity and rudeness. It really only serves to make you look very small and with no credibility. Get a grip on your anger. you can be quite informative if you really want to, so stick to the facts. Zvi

To: David Israel-Rosen who wrote (769)	5/7/1998 2:04:00 PM
From: InvestorLady	Read Replies (1) \| Respond to of 1491

No David, my cup is not half fool. Thanks SO much for taking me up on the olive branch I sent in private messages. Your bigness and kindness is underwhelming. Your insults show your character and you hurt yourself more than any attempt to discredit me, which seems to be your pleasure. Giving my opinion, right or wrong (preferabbly correct) gives me pleasure. And I like to challenge hype/look for balance. The point is, the release of the new drugs for June 1 HAS BEEN BURIED AND OVERLOOKED because it lacked substantial information. I believe we were looking forward to such a release, no? The two drugs are what matter to revenue streams NOW and should have been promoted as such. It is marvelous they updated on Tomaxafin, etc....but it should have been a separate release so that BOTH the material event and the pipeline event received respect. Very sloppy work. Lady